A Low-Carbohydrate, Ketogenic Diet Versus Orlistat for Weight Loss
|ClinicalTrials.gov Identifier: NCT00108524|
Recruitment Status : Completed
First Posted : April 18, 2005
Results First Posted : December 12, 2013
Last Update Posted : April 17, 2014
|Condition or disease||Intervention/treatment|
|Diabetes Mellitus Obesity||Behavioral: Low carbohydrate ketogenic diet Drug: Orlistat Behavioral: Low-fat diet|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||146 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||A Low-Carbohydrate, Ketogenic Diet Versus Orlistat for Weight Loss|
|Study Start Date :||July 2004|
|Primary Completion Date :||December 2007|
|Study Completion Date :||December 2007|
Experimental: Low Carbohydrate Ketogenic Diet
Participants receive dietary counseling over 48 weeks aimed at helping them to lower starch and sugar intake.
Behavioral: Low carbohydrate ketogenic diet
A low-carb diet limits carbohydrates - such as grains, starchy vegetables and fruit - and emphasizes dietary protein and fat.
Active Comparator: Low-Fat Diet plus Orlistat
Participants receive counseling on a low fat diet over 48 weeks aimed at reducing fat and calorie intake, and additionally receive Orlistat taken 3 times daily.
In addition to the low fat diet, Orlistat is taken 3 times daily.
Other Name: XenicalBehavioral: Low-fat diet
Participants receive counseling on a low fat diet over 48 weeks aimed at reducing fat and calorie intake
- Change From Baseline in Body Weight at 48 Weeks [ Time Frame: baseline and 48 weeks ]Body weight was measured using the same calibrated scale (Tanita Corp, Arlington Heights, Illinois) at each visit at the same time of day, with the participant wearing light clothing and no shoes.
- Change From Baseline in Risk Factors for Heart Disease (e.g., Lipid Profiles) at 48 Weeks [ Time Frame: baseline and 48 weeks ]Measured change in low-density lipoprotein cholesterol, or LDL-C, from baseline to 48 weeks.
- Change From Baseline in Blood Sugar at 48 Weeks [ Time Frame: Baseline and 48 weeks ]Measured change in Fasting glucose, mg/dL, from baseline to 48 weeks.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00108524
|United States, North Carolina|
|Durham VA Medical Center HSR&D COE|
|Durham, North Carolina, United States, 27705|
|Principal Investigator:||William S. Yancy, MD MHS||Durham VA Medical Center HSR&D COE|